X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1399) 1399
Book Review (181) 181
Report (144) 144
Publication (52) 52
Patent (48) 48
Newspaper Article (36) 36
Book / eBook (18) 18
Book Chapter (12) 12
Magazine Article (8) 8
Web Resource (4) 4
Newsletter (3) 3
Trade Publication Article (3) 3
Conference Proceeding (2) 2
Data Set (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1161) 1161
humans (862) 862
preservatives (479) 479
male (429) 429
female (417) 417
preservatives, pharmaceutical - adverse effects (393) 393
animals (331) 331
ophthalmology (282) 282
pharmacology & pharmacy (242) 242
preservatives, pharmaceutical - administration & dosage (232) 232
adult (223) 223
preservatives, pharmaceutical (218) 218
middle aged (208) 208
benzalkonium chloride (157) 157
aged (149) 149
glaucoma (132) 132
administration, topical (129) 129
ophthalmic solutions (125) 125
preservatives, pharmaceutical - pharmacology (124) 124
toxicology (124) 124
preservatives, pharmaceutical - toxicity (120) 120
thimerosal - adverse effects (116) 116
abridged index medicus (115) 115
preservatives, pharmaceutical - chemistry (114) 114
capital gains (109) 109
toxicity (106) 106
food science & technology (104) 104
present value (104) 104
stock prices (104) 104
in-vitro (99) 99
dose-response relationship, drug (97) 97
thimerosal (93) 93
safety (92) 92
child (90) 90
dividends (90) 90
earnings per share (90) 90
vaccines (89) 89
analysis (87) 87
prospective studies (86) 86
allergy (83) 83
preservative (83) 83
rats (83) 83
cosmetics (81) 81
dermatology (81) 81
rabbits (78) 78
stock exchanges (78) 78
benzalkonium compounds - administration & dosage (77) 77
infant (75) 75
adolescent (73) 73
food preservatives (73) 73
drug stability (72) 72
food (72) 72
research (72) 72
treatment outcome (72) 72
cosmetics industry (71) 71
ophthalmic solutions - administration & dosage (71) 71
parabens (71) 71
time factors (71) 71
double-blind method (70) 70
corporate profits (69) 69
mercury (69) 69
united states (69) 69
aged, 80 and over (68) 68
chemistry (68) 68
benzalkonium compounds - adverse effects (66) 66
glaucoma - drug therapy (65) 65
growth rate (65) 65
intraocular pressure - drug effects (65) 65
stockholders (65) 65
equity (64) 64
boards of directors (63) 63
efficacy (63) 63
chemistry, pharmaceutical (62) 62
dermatitis, allergic contact - etiology (62) 62
drugs (62) 62
antihypertensive agents - administration & dosage (60) 60
mice (60) 60
prevalence (60) 60
autism (58) 58
exposure (58) 58
latanoprost (57) 57
awards & honors (56) 56
ocular hypertension - drug therapy (56) 56
open-angle glaucoma (56) 56
pediatrics (56) 56
risk factors (56) 56
vaccines - adverse effects (56) 56
glaucoma, open-angle - drug therapy (55) 55
children (54) 54
health aspects (54) 54
antioxidants (53) 53
hypertension (52) 52
surgery (52) 52
child, preschool (51) 51
studies (50) 50
cornea - drug effects (49) 49
ophthalmic solutions - adverse effects (49) 49
bacteria (48) 48
human necessities (48) 48
hygiene (48) 48
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1597) 1597
French (63) 63
German (33) 33
Arabic (4) 4
Japanese (4) 4
Romanian (4) 4
Czech (3) 3
Russian (3) 3
Spanish (3) 3
Portuguese (2) 2
Swedish (2) 2
Dutch (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Ophthalmology, ISSN 0002-9394, 2009, Volume 147, Issue 4, pp. 725 - 735.e1
Journal Article
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2015, Volume 112, Issue 40, pp. 12498 - 12503
Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder. Some anecdotal reports suggest that ASD is related to exposure to ethyl mercury, in... 
Thimerosal | Autism | Pediatric vaccines | Rhesus macaque | Neuropathology | rhesus macaque | NUMBER | SAFETY | COVERAGE | MULTIDISCIPLINARY SCIENCES | pediatric vaccines | MACACA-NEMESTRINA | autism | CHILDREN | NEUROPSYCHOLOGICAL OUTCOMES | WOMEN | NONHUMAN PRIMATE MODEL | METHYLMERCURY | neuropathology | EXPOSURE | thimerosal | Autistic Disorder - chemically induced | Immunohistochemistry | Amygdala - drug effects | Cerebellum - drug effects | Neuropathology - methods | Calbindins - metabolism | Male | Macaca mulatta | Hippocampus - drug effects | Glial Fibrillary Acidic Protein - metabolism | Brain Diseases - chemically induced | Vaccination - methods | Time Factors | Microfilament Proteins - metabolism | Neurons - metabolism | Autistic Disorder - diagnosis | Neurons - drug effects | Thimerosal - administration & dosage | Animals, Newborn | Calcium-Binding Proteins - metabolism | Preservatives, Pharmaceutical - adverse effects | Brain Diseases - diagnosis | Cerebellum - metabolism | Amygdala - metabolism | Thimerosal - adverse effects | Blotting, Western | Hippocampus - metabolism | Vaccines - adverse effects | Animals | Glutamate Decarboxylase - metabolism | Preservatives, Pharmaceutical - administration & dosage | Vaccines - administration & dosage | Complications and side effects | Nervous system diseases | Pervasive developmental disorders | Vaccines | Health aspects | Risk factors | Mercury | Index Medicus | Biological Sciences
Journal Article
Journal Article
British Journal of Ophthalmology, ISSN 0007-1161, 12/2013, Volume 97, Issue 12, pp. 1510 - 1515
Journal Article
Advances in Therapy, ISSN 0741-238X, 11/2010, Volume 27, Issue 11, pp. 837 - 845
To investigate potentially adverse effects of different topical glaucoma medications and preservatives on cultured ocular epithelial cells.Confluent cultures... 
pharmaceutical preservatives | glaucoma | Rheumatology | Oncology | Internal Medicine | conjunctival epithelium | travoprost | benzalkonium chloride | corneal epithelium | polyquaternium-1 | latanoprost | polyquad | Medicine & Public Health | tafluprost | Pharmacology/Toxicology | Cardiology | Endocrinology | Glaucoma | Corneal epithelium | Polyquad | Benzalkonium chloride | Polyquaternium-1 | Conjunctival epithelium | Tafluprost | Pharmaceutical preservatives | Latanoprost | Travoprost | SYSTEM | MEDICINE, RESEARCH & EXPERIMENTAL | CHANG CONJUNCTIVAL | PRESERVATIVES | BIMATOPROST | TOXICITY | CORNEAL | IN-VITRO | CONJUNCTIVAL CHANGES | PHARMACOLOGY & PHARMACY | Cell Survival - drug effects | Polymers - administration & dosage | Humans | Cells, Cultured | Antihypertensive Agents - administration & dosage | Benzalkonium Compounds - administration & dosage | Glaucoma - drug therapy | Cloprostenol - analogs & derivatives | Preservatives, Pharmaceutical - toxicity | Dose-Response Relationship, Drug | Prostaglandins F, Synthetic - toxicity | Antihypertensive Agents - toxicity | Conjunctiva - drug effects | Prostaglandins F, Synthetic - administration & dosage | Benzalkonium Compounds - toxicity | Polymers - toxicity | Prostaglandins F | Epithelium, Corneal - drug effects | Ophthalmic Solutions | Preservatives, Pharmaceutical - administration & dosage | Administration, Topical | Conjunctiva - cytology | Medical colleges | Prostaglandins | Surface active agents | Analysis | Ophthalmic drugs | Fluorescence | Ophthalmology | Drug therapy | Health technology assessment
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 05/2010, Volume 88, Issue 3, pp. 329 - 336
Purpose: The purpose of this study was to investigate the tolerability and intraocular pressure (IOP) reducing effect of the first preservative-free... 
latanoprost | Taflotan | Preservative-free tafluprost ophthalmic solution | Xalatan | Tolerability | IOP | Patient satisfaction | Quality of life | LATANOPROST | SIGNS | Taflotan (R) | Xalatan (R) latanoprost | PHARMACODYNAMICS | OCULAR SYMPTOMS | patient satisfaction | TAFLUPROST | preservative-free tafluprost ophthalmic solution | tolerability | OPHTHALMOLOGY | quality of life | RECEPTOR AGONIST | Hyperemia - metabolism | Intraocular Pressure - drug effects | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Male | Hyperemia - prevention & control | Conjunctival Diseases - metabolism | Ocular Hypertension - drug therapy | Patient Satisfaction | Prostaglandins F, Synthetic - administration & dosage | Aged, 80 and over | Tonometry, Ocular | Adult | Female | Surveys and Questionnaires | Conjunctival Diseases - chemically induced | HLA-DR Antigens - metabolism | Conjunctival Diseases - prevention & control | Preservatives, Pharmaceutical - adverse effects | Prostaglandins F - administration & dosage | Benzalkonium Compounds - adverse effects | Ophthalmoscopy | Benzalkonium Compounds - administration & dosage | Prostaglandins F, Synthetic - adverse effects | Blepharitis - metabolism | Glaucoma, Open-Angle - drug therapy | Blepharitis - prevention & control | Blepharitis - chemically induced | Exfoliation Syndrome - drug therapy | Mucin 5AC - metabolism | Quality of Life | Hyperemia - chemically induced | Aged | Gonioscopy | Preservatives, Pharmaceutical - administration & dosage | Administration, Topical | Glaucoma | Prostaglandins | Analysis | Pharmacy | Ophthalmic drugs | Mucins | Fluorescein | Ophthalmology | Universities and colleges | Drug therapy | Index Medicus
Journal Article